Back to medications
Medication monograph

tirzepatide

Peptide AnaloguesAntidiabeticsGLP-1 Receptor AgonistsGLP-1 AgonistsGlucose-dependent Insulinotropic Polypeptide Receptor Agonist

Brands & formulations

Family members

MOUNJARO

Marketed
2.5 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO

Marketed
5 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO

Marketed
7.5 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO

Marketed
10 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO

Marketed
12.5 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO

Marketed
15 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO KWIKPEN

Marketed
2.5 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO KWIKPEN

Marketed
5 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO KWIKPEN

Marketed
7.5 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO KWIKPEN

Marketed
10 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO KWIKPEN

Marketed
12.5 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

MOUNJARO KWIKPEN

Marketed
15 MGSUBCUTANEOUSSOLUTION[ "tirzepatide" ]
Product monograph

Classification

Chemical class
Peptide Analogues
Clinical class
Antidiabetics, GLP-1 Receptor Agonists
Banks class
GLP-1 Agonists, Glucose-dependent Insulinotropic Polypeptide Receptor Agonist